LWAM
Legacy Wealth Asset Management’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $315K | Buy |
2,511
+91
| +4% | +$11.4K | 0.08% | 312 |
|
|
2025
Q1 | $331K | Buy |
2,420
+591
| +32% | +$80.9K | 0.09% | 288 |
|
|
2024
Q4 | $280K | Sell |
1,829
-347
| -16% | -$53.1K | 0.08% | 314 |
|
|
2024
Q3 | $422K | Buy |
2,176
+86
| +4% | +$16.7K | 0.11% | 270 |
|
|
2024
Q2 | $485K | Buy |
2,090
+92
| +5% | +$21.3K | 0.14% | 232 |
|
|
2024
Q1 | $431K | Buy |
1,998
+77
| +4% | +$16.6K | 0.12% | 253 |
|
|
2023
Q4 | $497K | Sell |
1,921
-10
| -0.5% | -$2.59K | 0.16% | 225 |
|
|
2023
Q3 | $496K | Buy |
1,931
+32
| +2% | +$8.22K | 0.18% | 198 |
|
|
2023
Q2 | $541K | Sell |
1,899
-2,000
| -51% | -$570K | 0.19% | 187 |
|
|
2023
Q1 | $1.08M | Sell |
3,899
-47
| -1% | -$13.1K | 0.39% | 73 |
|
|
2022
Q4 | $1.09M | Sell |
3,946
-147
| -4% | -$40.7K | 0.42% | 70 |
|
|
2022
Q3 | $1.09M | Buy |
4,093
+814
| +25% | +$217K | 0.48% | 60 |
|
|
2022
Q2 | $669K | Buy |
3,279
+70
| +2% | +$14.3K | 0.27% | 144 |
|
|
2022
Q1 | $676K | Buy |
3,209
+412
| +15% | +$86.8K | 0.24% | 157 |
|
|
2021
Q4 | $671K | Buy |
2,797
+296
| +12% | +$71K | 0.23% | 161 |
|
|
2021
Q3 | $708K | Buy |
2,501
+13
| +0.5% | +$3.68K | 0.32% | 129 |
|
|
2021
Q2 | $862K | Buy |
2,488
+82
| +3% | +$28.4K | 0.38% | 98 |
|
|
2021
Q1 | $673K | Buy |
2,406
+78
| +3% | +$21.8K | 0.31% | 137 |
|
|
2020
Q4 | $570K | Buy |
+2,328
| New | +$570K | 0.29% | 142 |
|